Investing.com - Clover Health Investments (NASDAQ: CLOV) reported third quarter EPS of $-0.0200, $0.02 better than the analyst estimate of $-0.0400. Revenue for the quarter came in at $331M versus the consensus estimate of $346.27M.
Guidance
Clover Health Investments sees FY 2024 revenue of $1.3500B-$1.3700B versus the analyst consensus of $1.3900B.
Clover Health Investments's stock price closed at $4.36. It is up 134.1400% in the last 3 months and up 371.0700% in the last 12 months.
Clover Health Investments saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Clover Health Investments's stock price’s past reactions to earnings here.
According to InvestingPro, Clover Health Investments's Financial Health score is "great performance".
Check out Clover Health Investments's recent earnings performance, and Clover Health Investments's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar